You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 9, 2025

Details for Patent: 8,399,508


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,399,508
Title:Olopatadine formulations for topical nasal administration
Abstract: Topical formulations of olopatadine for treatment of allergic or inflammatory disorders of the nose are disclosed. The aqueous formulations contain approximately 0.6% (w/v) of olopatadine.
Inventor(s): Singh; Onkar N. (Arlington, TX), Wall; G. Michael (Fort Worth, TX), Jani; Rajni (Fort Worth, TX), Chowhan; Masood A. (Arlington, TX), Han; Wesley Wehsin (Arlington, TX)
Assignee: Alcon Pharmaceuticals Ltd. (Fribourg, CH)
Application Number:13/173,608
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 8,399,508

Introduction

United States Patent 8,399,508, titled "Olopatadine formulations for topical nasal administration," is a significant patent in the field of pharmaceuticals, particularly for the treatment of allergic or inflammatory disorders of the nose. This article delves into the details of the patent's scope, claims, and the broader patent landscape it operates within.

Overview of the Patent

The patent, granted on March 19, 2013, pertains to aqueous formulations of olopatadine, an antihistamine used to treat allergic rhinitis and other nasal allergies. These formulations are designed for topical nasal administration, offering a targeted and effective treatment option[1].

Patent Scope

The scope of a patent is crucial as it defines the boundaries of what is protected by the patent. For US Patent 8,399,508, the scope is determined by the claims section, which outlines the specific aspects of the invention that are protected.

Independent Claims

Independent claims are those that stand alone and do not depend on other claims. In this patent, the independent claims focus on the composition of the olopatadine formulations, including the concentration of olopatadine, the type of aqueous vehicle used, and any additional ingredients such as preservatives or pH adjusters[1].

Dependent Claims

Dependent claims build upon the independent claims and provide additional specificity. For example, dependent claims might specify particular concentrations of olopatadine, specific preservatives, or the pH range of the formulation[1].

Claim Language and Metrics

The language and structure of patent claims are critical in defining the patent's scope. Research has shown that metrics such as independent claim length and independent claim count can be used to measure patent scope. Patents with narrower claims, as measured by these metrics, tend to have a higher probability of grant and a shorter examination process[3].

Examination Process

The examination process for US Patent 8,399,508 would have involved a thorough review by patent examiners to ensure that the claims were novel, non-obvious, and adequately described. The process tends to narrow the scope of patent claims, making them more specific and less broad. This narrowing is reflected in changes to claim length and count during the examination period[3].

Patent Claims and Patent Scope

The claims in US Patent 8,399,508 are designed to be clear and specific, ensuring that the invention is well-defined and distinguishable from prior art. The patent scope, as defined by these claims, protects the unique aspects of the olopatadine formulations while allowing for innovation in related areas.

Economic and Innovation Impact

The granting of US Patent 8,399,508 can have significant economic and innovation impacts. Patents that are well-defined and of high quality can incentivize further innovation by providing clear boundaries and encouraging licensing and collaboration. However, overly broad patents can lead to increased litigation costs and diminish innovation incentives[3].

Industry Relevance

In the pharmaceutical industry, patents like US 8,399,508 are crucial for protecting intellectual property and ensuring that companies can recoup their investment in research and development. The specific formulation and administration method protected by this patent can provide a competitive edge in the market for allergic rhinitis treatments.

Competitive Landscape

The competitive landscape for nasal allergy treatments is robust, with several other patents and products available. For instance, patents related to the use of mometasone for treating allergic rhinitis highlight the diverse approaches to nasal allergy treatment[4].

Legal and Regulatory Considerations

Patent holders must comply with various legal and regulatory requirements. This includes maintaining the patent through periodic payments and ensuring that the patent does not infringe on existing patents. Workshops and resources provided by the USPTO, such as "The Path to a Patent, Part V: Understanding the role of claims in a patent application," can be invaluable for navigating these complexities[5].

Public Access and Transparency

The USPTO provides extensive datasets and resources for analyzing patent claims and scope. The Patent Claims Research Dataset, for example, offers detailed information on claims from US patents granted between 1976 and 2014, which can be used to analyze trends and metrics related to patent scope[2].

Future Trends and Innovations

As the field of pharmaceuticals continues to evolve, patents like US 8,399,508 will play a crucial role in driving innovation. Future trends may include the development of new formulations, combination therapies, and advanced delivery systems, all of which will be influenced by the existing patent landscape.

Key Takeaways

  • Patent Scope: Defined by the claims section, which outlines the specific aspects of the invention protected.
  • Claim Language: Metrics such as independent claim length and count are used to measure patent scope.
  • Examination Process: Tends to narrow the scope of patent claims, making them more specific.
  • Economic Impact: Well-defined patents can incentivize innovation and protect intellectual property.
  • Industry Relevance: Crucial for protecting IP and ensuring competitive advantage in the pharmaceutical industry.
  • Legal and Regulatory Considerations: Patent holders must comply with maintenance payments and non-infringement requirements.

FAQs

Q: What is the main subject of US Patent 8,399,508? A: The main subject is olopatadine formulations for topical nasal administration to treat allergic or inflammatory disorders of the nose.

Q: How is the scope of a patent determined? A: The scope is determined by the claims section of the patent, which outlines the specific aspects of the invention that are protected.

Q: What metrics are used to measure patent scope? A: Metrics such as independent claim length and independent claim count are used to measure patent scope[3].

Q: How does the examination process affect patent claims? A: The examination process tends to narrow the scope of patent claims, making them more specific and less broad[3].

Q: Why are well-defined patents important for innovation? A: Well-defined patents can incentivize further innovation by providing clear boundaries and encouraging licensing and collaboration[3].

Sources

  1. Olopatadine formulations for topical nasal administration - Google Patents
  2. Patent Claims Research Dataset - USPTO
  3. Patent Claims and Patent Scope - SSRN
  4. Treatment of allergic rhinitis using a combination of mometasone - Google Patents
  5. The Path to a Patent, Part V: Understanding the role of claims in a patent application - USPTO

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,399,508

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 8,399,508

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 034619 ⤷  Subscribe
Austria 295149 ⤷  Subscribe
Australia 2002310461 ⤷  Subscribe
Brazil 0210707 ⤷  Subscribe
Brazil PI0210707 ⤷  Subscribe
Canada 2447924 ⤷  Subscribe
China 1211125 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.